絞り込み結果
7 件並び順
1:22:59EN
20VC with Harry Stebbings· 2024年11月22日ポッドキャスト · 2 人Dan Fougere on Building Datadog’s Sales Motion and Protecting Priceゲスト Dan Fougere · ホスト Harry StebbingsThe former Datadog CRO explains qualification, enterprise sales, discount discipline and the people behind a repeatable process.
1:23:01EN20VC with Harry Stebbings· 2024年9月20日ポッドキャスト · 2 人Phil Carter on Growth Loops and Consumer Subscription Economicsゲスト Phil Carter · ホスト Harry StebbingsThe growth advisor explains acquisition, retention, paywalls and pricing, and why sustainable consumer subscriptions require more than buying traffic.
1:24:54EN20VC with Harry Stebbings· 2024年5月27日ポッドキャスト · 2 人Jason Lemkin on SaaS Investing, Churn and Seed Valuationsゲスト Jason Lemkin · ホスト Harry StebbingsThe SaaStr founder revisits successful and disappointing deals, explains his diligence process and assesses the economics of seed investing.
52:52EN20VC with Harry Stebbings· 2024年4月19日ポッドキャスト · 2 人Girish Mathrubootham on Freshworks Pricing, Products and Scalingゲスト Girish Mathrubootham · ホスト Harry StebbingsThe Freshworks founder shares lessons from self-service software, a multi-product strategy, executive hiring and investing in Indian startups.
1:03:31EN20VC with Harry Stebbings· 2024年3月6日ポッドキャスト · 2 人Peter Wagner on Venture Cycles, Founders and Price Disciplineゲスト Peter Wagner · ホスト Harry StebbingsThe Wing founding partner reflects on decades of investing, the Snowflake round he did not lead and the risks of capital-intensive businesses.
1:01:37EN20VC with Harry Stebbings· 2023年9月8日ポッドキャスト · 2 人Doug Adamic on Sales Discovery, Pipeline Quality and Why He Resists Discountingゲスト Doug Adamic · ホスト Harry StebbingsThe Brex revenue leader explains how he connects customer outcomes to urgency, coaches sales teams and builds a repeatable process.
30:53EN20VC with Harry Stebbings· 2022年2月8日ポッドキャスト · 2 人Mark Cuban on Cost Plus Drugs, Hiring and Healthcare Pricingゲスト Mark Cuban · ホスト Harry StebbingsIn a 2022 interview, Cuban describes the pharmacy’s early pricing model, his self-funded venture and his views on the US healthcare system.